🇺🇸 FDA
Patent

US 10300115

Methods and compositions for modulating immune tolerance

granted A61KA61K38/195A61K38/45

Quick answer

US patent 10300115 (Methods and compositions for modulating immune tolerance) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue May 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K38/195, A61K38/45, A61K38/465, A61K45/06